Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic’s many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Dr. Kullo's lab uses family history, linkage and association studies, and sequencing to research the genetics of arterial plaques (atherosclerosis).
The Atherosclerosis and Lipid Genomics Lab collaborates on projects conducting genetic studies of cardiovascular diseases using the electronic health record (EHR).
Dr. Kullo's lab is addressing challenges in implementing genomic medicine using the EHR through eMERGE projects, the MI-Genes study and other projects.
The lab is studying the prevalence, awareness, control and outcomes of familial hypercholesterolemia using electronic health records and registries such as CASCADE.
The Atherosclerosis and Lipid Genomics Lab is studying associations between circulating biomarkers and cardiovascular disease, such as myocardial infarction, ischemic stroke and heart failure.
Dr. Kullo's research team is investigating factors that influence arterial function and the effect of arterial function on ventricular function, such as through the GENOA study.
Research projects include using informatics approaches to ascertain PAD from the electronic health record, conducting population-based epidemiologic studies, and developing an automated estimation of prognostic scores for PAD with linkage to clinical decision support.
The lab created and maintains a biorepository to assist in the discovery of new biomarkers for vascular diseases, including peripheral artery disease and aortic aneurysm.
Collaborators from Mayo Clinic and across the country work with Dr. Kullo's team in an effort to advance understanding about the genetics of atherosclerotic cardiovascular diseases and hereditary lipid disorders.
Mayo Clinic is a not-for-profit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.